Essure Discontinuation Doesn’t Mean the End to FDA Scrutiny
Bayer has already decided to stop selling the controversial birth control device, but FDA says it will continue to monitor the long-term safety of Essure.
Predict and Prevent: The Emergence of Real-Time Sensor-Based Care
Wearables are being used for everything from smoking cessation to epilepsy management.
How a Coaxial Alternative Could Make Way for Smaller Catheters
How a Coaxial Alternative Could Make Way for Smaller Catheters
Why Are Devices the Last-in-Line Treatment for Chronic Pain?
Despite the ongoing opioid crisis in the United States, guidelines don’t list alternative device therapies such as neurostimulators as options for treating chronic pain. What gives?
Is 2019 Going to Be a Standout Year for TAVR?
JenaValve has received a nod from FDA to expand enrollment in an IDE of its TAVR system. The measure comes at a time when the TAVR landscape is expected to shift.
Auris Scores Big with $200M Raise for Robotics Platform
The Redwood City, CA-based company’s financing raise is the perfect example of the strength and support the robotics market now commands in healthcare.
How Can Nanotechnologies Aid Implantable Drug-Delivery Systems?
An industry expert shares how emerging micro and nanotechnologies could shape the next generation of implantable drug-delivery systems.
J&J Subsidiary Launches IDE Study for AF
The study will evaluate Biosense Webster’s Heliostar radiofrequency balloon ablation catheter for the treatment of symptomatic drug refractory recurrent paroxysmal (intermittent) atrial fibrillation.
4 Factors to Consider When Selecting a Spring Manufacturer
Cost and timeliness alone shouldn’t drive your decision.
Boston Sci Puts up $4B for BTG
The Marlborough, MA-based company hasn’t been shy about building up its portfolio through M&A, the only question now is can it slip in another deal before the end of the year.
